Any mention of SUBCUTANEOUS administration
Factors to evaluate include: Experience: Suppliers with a track record in pharmaceutical labeling are more likely to understand the industrys strict requirements
The recipients were followed at six, 12, 36 and 60 months
Many people describe it as a quieter relationship with food
Techniques such as taking deep breaths or blowing air out during the injection may help a person relax
According to the NICE Clinical Knowledge Summary (CKS) and the British National Formulary (BNF) , the standard treatment for B12 deficiency without neurological symptoms involves: Hydroxocobalamin 1 mg intramuscularly three times weekly for two weeks Followed by maintenance doses of 1 mg every three months For patients with neurological symptoms (such as paraesthesia, numbness, cognitive changes, or gait disturbances), more intensive treatment is required: Hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement occurs Followed by 1 mg every two months for maintenance Pernicious anaemia , an autoimmune condition where the body cannot produce intrinsic factor, requires lifelong treatment